Respuesta :
Answer:
Step-by-step explanation:
From the summary of the given data;
After the second dose, 137 of 452 subjects in the experimental group (group 1) experienced drowsiness as a side effect.
Let consider [tex]p_1[/tex] to be the probability of those that experience the drowsiness in group 1
[tex]p_1[/tex] = [tex]\dfrac{137}{452}[/tex]
[tex]p_1[/tex] = 0.3031
After the second dose, 31 of 99 subjects in the control group (group 2) experienced drowsiness as a side effect.
Let consider [tex]p_2[/tex] to be the probability of those that experience the drowsiness in group 1
[tex]p_2[/tex] = [tex]\dfrac{31}{99}[/tex]
[tex]p_2[/tex] = 0.3131
The objective is to be able to determine if the evidence suggest that a lower proportion of subjects in group 1 experienced drowsiness as a side effect than subjects in group 2 at the α=0.05 level of significance.
In order to do that; we have to state the null and alternative hypothesis; carry out our test statistics and make conclusion based on it.
So; the null and the alternative hypothesis can be computed as:
[tex]H_o :p_1 =p_2[/tex]
[tex]H_a= p_1<p_2[/tex]
The test statistics is computed as follows:
[tex]Z = \dfrac{p_1-p_2}{\sqrt{p_1 *\dfrac{1-p_1}{n_1} +p_2 *\dfrac{1-p_2}{n_2}} }[/tex]
[tex]Z = \dfrac{0.3031-0.3131}{\sqrt{0.3031 *\dfrac{1-0.3031}{452} +0.3131 *\dfrac{1-0.3131}{99}} }[/tex]
[tex]Z = \dfrac{-0.01}{\sqrt{0.3031 *\dfrac{0.6969}{452} +0.3131 *\dfrac{0.6869}{99}} }[/tex]
[tex]Z = \dfrac{-0.01}{\sqrt{0.3031 *0.0015418 +0.3131 *0.0069384} }[/tex]
[tex]Z = \dfrac{-0.01}{\sqrt{4.6731958*10^{-4}+0.00217241304} }[/tex]
[tex]Z = \dfrac{-0.01}{0.051378 }[/tex]
Z = - 0.1946
At the level of significance ∝ = 0.05
From the standard normal table;
the critical value for Z(0.05) = -1.645
Decision Rule: Reject the null hypothesis if Z-value is lesser than the critical value.
Conclusion: We do not reject the null hypothesis because the Z value is greater than the critical value. Therefore, we cannot conclude that a lower proportion of subjects in group 1 experienced drowsiness as a side effect than subjects in group 2